Get ready for a new eCorner experience!
Later this summer, eCorner will become part of the website for STVP, the Stanford Engineering Entrepreneurship Center. You'll be able to access all eCorner content at stvp.stanford.edu. Existing links and bookmarks will redirect. Sign up for our newsletter to stay in the loop!

Pharmaceutical Companies: Challenges in Developing New Therapeutic Products

Gordon Ringold, Affymax Research Institute

Ringold talks about how the pharmaceutical industry is built on failure and inefficiency and has a small success rate. This recognition led to Surromed. The low success rate is driving the consolidation of companies, which is giving rise to mega players. Now a blockbuster product has to be a multibillion product. This can only change with a change in the processes it uses. New biotech companies are starving for funding and cash, he notes.